A detailed history of Tower Research Capital LLC (Trc) transactions in Lensar, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,092 shares of LNSR stock, worth $9,445. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,092
Previous 1,289 15.28%
Holding current value
$9,445
Previous $5,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$3.99 - $5.44 $786 - $1,071
-197 Reduced 15.28%
1,092 $5,000
Q2 2024

Aug 13, 2024

SELL
$3.0 - $4.88 $4,752 - $7,729
-1,584 Reduced 55.13%
1,289 $5,000
Q1 2024

May 15, 2024

BUY
$3.25 - $5.0 $4,559 - $7,015
1,403 Added 95.44%
2,873 $9,000
Q4 2023

Feb 13, 2024

BUY
$2.01 - $3.51 $2,598 - $4,538
1,293 Added 730.51%
1,470 $5,000
Q3 2023

Nov 14, 2023

BUY
$3.02 - $4.45 $534 - $787
177 New
177 $0
Q1 2023

May 09, 2023

BUY
$2.19 - $3.27 $3,458 - $5,163
1,579 Added 61.46%
4,148 $10,000
Q4 2022

Feb 10, 2023

SELL
$2.7 - $5.9 $240 - $525
-89 Reduced 3.35%
2,569 $7,000
Q3 2022

Nov 10, 2022

BUY
$4.94 - $7.0 $3,334 - $4,725
675 Added 34.04%
2,658 $15,000
Q2 2022

Aug 15, 2022

BUY
$6.15 - $7.94 $9,114 - $11,767
1,482 Added 295.81%
1,983 $13,000
Q1 2022

May 12, 2022

SELL
$5.8 - $8.2 $2,824 - $3,993
-487 Reduced 49.29%
501 $4,000
Q4 2021

Feb 14, 2022

BUY
$5.9 - $7.84 $4,897 - $6,507
830 Added 525.32%
988 $6,000
Q3 2021

Nov 15, 2021

SELL
$7.5 - $8.88 $52,012 - $61,582
-6,935 Reduced 97.77%
158 $1,000
Q2 2021

Aug 16, 2021

BUY
$6.87 - $8.66 $14,743 - $18,584
2,146 Added 43.38%
7,093 $61,000
Q1 2021

May 17, 2021

SELL
$6.28 - $9.56 $10,205 - $15,535
-1,625 Reduced 24.73%
4,947 $36,000
Q4 2020

Feb 16, 2021

BUY
$6.7 - $12.2 $44,032 - $80,178
6,572 New
6,572 $48,000

Others Institutions Holding LNSR

About LENSAR, Inc.


  • Ticker LNSR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 11,021,000
  • Market Cap $95.3M
  • Description
  • LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in...
More about LNSR
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.